tirzepatide cardiovascular outcome trial cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says tirzepatide outcomes trial results – Effects of tirzepatide on circulatory

Doc will come to you

(PubMed) Bermingham EN, Hesketh JE, Sinclair BR, Koolaard JP, Roy NC

Refunds are issued only in cases of medical disqualification by a licensed provider

Notably, the observed reductions in the odds of substance use disorders, including a 74% decrease in the odds of AUD, a 69% reduction for OUD, a 68% reduction for NUD, and a 75% reduction for CUD, among GLP-1 RA users were consistent with emerging preclinical and clinical studies showing that GLP-1 RA modulates reward pathways in the brain to reduce SUD (17, 23)

Mounjaro contains tirzepatide, which mimics two metabolic hormones, GLP-1 and GIP